We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6808:HKEXSun Art Retail Group Limited Analysis

Data as of 2026-08-26 - not real-time

HK$1.06

Latest Price

8/10Risk

Risk Level: High

Executive Summary

At HKD 1.06, Sun Art Retail Group Limited shows no decisive moving-average alignment, leaving the trend neutral. The last 30 days have lost 5.4%. Momentum indicators put RSI at 42.1 (neutral) with MACD reading bearish. Recent trading has carved out support near HKD 1.03 and resistance around HKD 1.36.
Valuation screens as undervalued, on a P/E of 13.2 with no clean sector comparison available. Analyst price targets sit 49.6% above the current price. Revenue is contracting at 10.6% on a -0.5% profit margin. The 16.35% dividend yield looks stretched against payout coverage.
The composite risk read is 8/10, putting it in high territory. With 30-day volatility of 43.1%, a beta of 0.02 and a maximum drawdown of 56.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.

Top Market Events

Detailed price information for Sun Art Retail Group Ltd SURRF from The Globe and Mail including charting and trades.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Trading below the 200-day average of 1.48
  • MACD momentum is negative
  • 30-day price change of -5.4%

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Dividend yield of 16.35% looks stretched against payout coverage
  • Trading below the 200-day average of 1.48
  • Analyst targets imply +49.6% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • Dividend yield of 16.35% looks stretched against payout coverage
  • Negative profit margin of -0.5%
  • Analyst targets imply +49.6% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth-10.60%
Profit Margin-0.50%
P/E Ratio13.2
ROE-1.73%
ROA0.12%
Debt/Equity43.45
P/B Ratio0.5
Op. Cash FlowHK$634.0M
Free Cash FlowHK$3.1B

Technical Analysis

TrendNeutral
RSI42.1
SupportHK$1.03
ResistanceHK$1.36
MA 20HK$1.11
MA 50HK$1.10
MA 200HK$1.48
MACDBearish
VolumeIncreasing
Fear & Greed Index93.84

Valuation

Fair ValueHK$4.40
Target PriceHK$1.59
Upside/Downside49.63%
GradeUndervalued
TypeValue
Dividend Yield16.35%

Risk Assessment

Beta0.02
Volatility43.07%
Sector RiskHigh
Reg. RiskLow
Geo RiskHigh
Currency RiskHigh
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.